Hypertension Clinical Trial
Official title:
Psychophysiologic Stress, Exercise, & Autonomic Control
This study will evaluate the effect of an aerobic training program versus a strength training program on the autonomic nervous system at rest and in response to challenge.
The purpose of this study is to compare the effectiveness of an aerobic exercise program
versus a strength training program in altering RR interval and blood pressure variability as
indices of autonomic nervous system regulation of the cardiovascular system. Subjects will
be tested at rest and in response to challenge.
This study will enroll healthy, young (age 18-45) sedentary individuals at Columbia
University Medical Center and St. John's University. At an initial screening visit,
potential participants will be screened for exercise activity and will also undergo a test
of aerobic capacity. Subjects will be eligible if they are not exercising regularly and do
not exceed American Heart Association standards for average fitness (VO2max ≤ 43 and 37
ml/kg/min for men and women respectively). Exclusion criteria include current symptoms of
affective disorder, psychosis, or substance abuse, current usage of psychotropic medication,
and any medical condition that affected the autonomic nervous system or cardiovascular
system.
Eligible participants will then be randomly assigned to 12 weeks of either an aerobic
conditioning program or a strength training program. At study entry, heart rate, respiratory
rate, and blood pressure will be measured; an ECG will be used to measure heart activity.
Questionnaires will be completed to assess anger, tension, depression, and fatigue.
Participants in the aerobic conditioning program will attend four 1-hour exercise sessions
per week, which will focus on increasing cardiovascular fitness through running and other
forms of aerobic exercise. The strength training program will also include four sessions per
week, with the focus on increasing muscle endurance and strength. At the end of the 12-week
programs, participants will begin a 4-week period of deconditioning, during which they will
discontinue all exercise. Evaluations will be repeated at the end of the 12-week programs,
and at the end of the 4-week deconditioning period.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
| Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
| Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
| Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
| Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
| Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
| Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
| Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
| Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
| Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
| Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
| Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
| Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |